| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.083 | 0.2 |